Inventor
MOELLER ACHIM
DE47 patents
⚠️ This page may combine multiple inventors who share the name “MOELLER ACHIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BASF AG
10 patentsUS5231024AJul 27, 1993
Monoclonal antibodies against human tumor necrosis factor (tnf), and use thereof
BASF AG481 citations98
US5344915ASep 6, 1994
Proteins and the preparation thereof
BASF AG55 citations94
US6630493B1Oct 7, 2003
Heterocyclically substituted amides, their preparation and use
BASF AG35 citations92
US6251917B1Jun 26, 2001
Benzamidoaldehydes and their use as cysteine protease inhibitors
BASF AG31 citations92
US6103720AAug 15, 2000
Ketobenzamides as calpain inhibitors
BASF AG45 citations92
US5180811AJan 19, 1993
Proteins having a tnf action comprising tnf-fibromectin fusion protein
BASF AG24 citations91
US4966894AOct 30, 1990
Polysulfated heparins for treating diseases caused by retroviruses
BASF AG22 citations79
US6172072B1Jan 9, 2001
Heterocyclically substituted benzamides and their use in fighting diseases
BASF AG12 citations74
US5157106AOct 20, 1992
N-terminal deletions of lymphotoxin, their preparation and use
BASF AG0 citations48
US6472587B1Oct 29, 2002
Production of a 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid or 7-chloro-3-methyllquinoline-8-carboxylic acid-tolerant plant by expressing an exogenous 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid or 7-chloro-3-methyllquinoline-8-carboxylic acid-binding antibody in the plant
BASF AG0 citations46
ABBOTT LAB
7 patentsUS6436925B1Aug 20, 2002
Substituted benzamides, their production and their use as cysteine protease inhibitors
ABBOTT LAB59 citations96
US6562827B1May 13, 2003
Heterocyclically substituted amides used as calpain inhibitors
ABBOTT LAB50 citations92
US6482832B1Nov 19, 2002
Heterocyclically substituted amides, their production and their use
ABBOTT LAB25 citations92
US6448254B1Sep 10, 2002
Substituted amides, their production and their use
ABBOTT LAB53 citations92
US6436949B1Aug 20, 2002
Heterocyclically substituted benzamides and their use
ABBOTT LAB15 citations84
US6380220B1Apr 30, 2002
Derivatives from piperidine-keto acid, their preparation and use
ABBOTT LAB11 citations73
US7906120B2Mar 15, 2011
Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)
ABBOTT LAB0 citations49
ABBOTT GMBH & CO KG
7 patentsUS7728012B2Jun 1, 2010
Carboxamide compounds and their use as calpain inhibitors
ABBOTT GMBH & CO KG8 citations83
US7491729B2Feb 17, 2009
3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof
ABBOTT GMBH & CO KG9 citations83
US6753327B1Jun 22, 2004
Substituted amides, their preparation and use
ABBOTT GMBH & CO KG10 citations73
US7956093B2Jun 7, 2011
Substituted amides, their preparation and use
ABBOTT GMBH & CO KG4 citations62
US7799809B2Sep 21, 2010
Carboxamide compounds and their use as calpain inhibitors
ABBOTT GMBH & CO KG3 citations62
US7276500B2Oct 2, 2007
Substituted amides, their preparation and use
ABBOTT GMBH & CO KG1 citations52
US9139557B2Sep 22, 2015
Carboxamide compounds and their use as calpain inhibitors
ABBOTT GMBH & CO KG0 citations51
ABBVIE DEUTSCHLAND
7 patentsUS10464976B2Nov 5, 2019
Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
ABBVIE DEUTSCHLAND2 citations71
US9828381B2Nov 28, 2017
Substituted pyrazolopyrimidines and method of use
ABBVIE DEUTSCHLAND3 citations70
US9567325B2Feb 14, 2017
Carboxamide compounds and their use as calpain inhibitors
ABBVIE DEUTSCHLAND0 citations52
US9527811B2Dec 27, 2016
Carboxamide compounds and their use as calpain inhibitors
ABBVIE DEUTSCHLAND0 citations52
US10040852B2Aug 7, 2018
Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof
ABBVIE DEUTSCHLAND0 citations51
US9255146B2Feb 9, 2016
Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof
ABBVIE DEUTSCHLAND0 citations51
US10155770B2Dec 18, 2018
Substituted pyrazolopyrimidines and method of use
ABBVIE DEUTSCHLAND0 citations49
MACK HELMUT
3 patentsUS8283363B2Oct 9, 2012
Carboxamide compounds and their use as calpain inhibitors
MACK HELMUT5 citations72
US9018206B2Apr 28, 2015
Carboxamide compounds and their use as calpain inhibitors
MACK HELMUT0 citations51
US8236798B2Aug 7, 2012
Carboxamide compounds and their use as calpain inhibitors
MACK HELMUT0 citations51
WOOD INNOVATIONS LTD
3 patentsUS10814936B2Oct 27, 2020
Core layer having wood elements, in particular wood elements having a corrugated structure
WOOD INNOVATIONS LTD1 citations68
US10053191B2Aug 21, 2018
Core layer having wood elements, in particular wood elements having a corrugated structure
WOOD INNOVATIONS LTD4 citations68
US12486664B2Dec 2, 2025
Core layer having wood elements, in particular wood elements having a corrugated structure
WOOD INNOVATIONS LTD0 citations58
KLING ANDREAS
3 patentsUS8906941B2Dec 9, 2014
Carboxamide compounds and their use as calpain inhibitors
KLING ANDREAS0 citations50
US8598211B2Dec 3, 2013
Carboxamide compounds and their use as calpain inhibitors IV
KLING ANDREAS1 citations49
US8436034B2May 7, 2013
Carboxamide compounds and their use as calpain inhibitors
KLING ANDREAS0 citations47
MOELLER ACHIM
2 patentsUS7131472B2Nov 7, 2006
Method for the production of a three-dimensional, flexibly deformable surface element
MOELLER ACHIM1 citations47
US10245749B2Apr 2, 2019
Method and apparatus for the fabrication of an endless band from a fiber material block, endless band and fiber material block
MOELLER ACHIM0 citations29